1 | decades | 2,910 |
2 | decade | 2,525 |
3 | century | 1,153 |
4 | centuries | 404 |
5 | millennia | 44 |
6 | half-century | 15 |
7 | 20years | 7 |
8 | lodging | 7 |
9 | 15years | 5 |
10 | direct-personal | 5 |
11 | picoseconds | 5 |
12 | 51-year | 4 |
13 | chayamansa | 4 |
14 | d.p.i. | 4 |
15 | dgou | 4 |
16 | thousand-fold | 4 |
17 | 61-year | 3 |
18 | anokye | 3 |
19 | beta-hsdh | 3 |
20 | mulilo | 3 |
21 | pcv-doses | 3 |
22 | 1-s.d | 2 |
23 | 37-year | 2 |
24 | 39-year | 2 |
25 | 52-year | 2 |
26 | 56-year | 2 |
27 | 76-year | 2 |
28 | 9weeks | 2 |
29 | arm-parallel | 2 |
30 | asphytic | 2 |
31 | climbs | 2 |
32 | endoscopists-in-training | 2 |
33 | eu-countries | 2 |
34 | follow-up/death | 2 |
35 | high-index | 2 |
36 | homo-oligomer | 2 |
37 | interglacial | 2 |
38 | rhg-csfs | 2 |
39 | souzae | 2 |
40 | tetrabutylester | 2 |
41 | videocamera | 2 |
42 | -participants | 1 |
43 | 0.40+/-0.43 | 1 |
44 | 1,2,3,4-tetrazines | 1 |
45 | 10-20years | 1 |
46 | 12-days | 1 |
47 | 151.8/79.7 | 1 |
48 | 18-yr | 1 |
49 | 2-diazo-1,2-diarylethanones | 1 |
50 | 36-hours | 1 |
51 | 387.61 | 1 |
52 | 41-year | 1 |
53 | 43-year | 1 |
54 | 48-yr | 1 |
55 | 54year- | 1 |
56 | 55-year- | 1 |
57 | 57-year | 1 |
58 | 63-year | 1 |
59 | 71-year | 1 |
60 | 770-221 | 1 |
61 | acyls-groups | 1 |
62 | allopatrically-formed | 1 |
63 | aminoestrogens | 1 |
64 | anastrozole.ais | 1 |
65 | anhydrophytosphingosines | 1 |
66 | assay® | 1 |
67 | at-biased | 1 |
68 | avaoli | 1 |
69 | aw06 | 1 |
70 | balanced-randomized | 1 |
71 | bavry | 1 |
72 | bites.1 | 1 |
73 | block/first | 1 |
74 | blood-draw | 1 |
75 | brush-applied | 1 |
76 | catecholamine-o-methyltransferase | 1 |
77 | chidren | 1 |
78 | chlorocarbons | 1 |
79 | cis-aligned | 1 |
80 | cis-vertices | 1 |
81 | citadels | 1 |
82 | cohorts.furthermore | 1 |
83 | complications.there | 1 |
84 | course-year | 1 |
85 | days/weeks | 1 |
86 | decennium | 1 |
87 | depression.twenty-three | 1 |
88 | di-nor-sesquiterpenoids | 1 |
89 | due-date | 1 |
90 | electron-volts | 1 |
91 | ergotamine-type | 1 |
92 | experienes | 1 |
93 | fast-access | 1 |
94 | fixed-cadence | 1 |
95 | formicicum | 1 |
96 | fourteen-week | 1 |
97 | free-market | 1 |
98 | go-trial | 1 |
99 | groups.however | 1 |
100 | guoup | 1 |
101 | half-decade | 1 |
102 | heathcare | 1 |
103 | hormokines | 1 |
104 | immunohematologic | 1 |
105 | intensions | 1 |
106 | issue/month | 1 |
107 | itbs-treatment | 1 |
108 | m539i | 1 |
109 | microtechnic | 1 |
110 | minutes.pimecrolimus | 1 |
111 | naphthofuranoxepin | 1 |
112 | non-furanocoumarins | 1 |
113 | o05 | 1 |
114 | oligostilbenoids | 1 |
115 | p53-ict | 1 |
116 | parent/grandparent | 1 |
117 | placebo-responders | 1 |
118 | polyprocess | 1 |
119 | pseudoknots | 1 |
120 | re-proposed | 1 |
121 | regio-isomers | 1 |
122 | rheas | 1 |
123 | rippstein | 1 |
124 | schedules-birth | 1 |
125 | sictts | 1 |
126 | spiroketals | 1 |
127 | studies.overall | 1 |
128 | studies/metaanalyses | 1 |
129 | subpatterns | 1 |
130 | three-month-period | 1 |
131 | town-pantelimon | 1 |
132 | typia | 1 |
133 | year-groups | 1 |
134 | years-first | 1 |
135 | δ-retroviruses | 1 |
1 | -participants | 1 |
2 | 0.40+/-0.43 | 1 |
3 | 1,2,3,4-tetrazines | 1 |
4 | 1-s.d | 2 |
5 | 10-20years | 1 |
6 | 12-days | 1 |
7 | 151.8/79.7 | 1 |
8 | 15years | 5 |
9 | 18-yr | 1 |
10 | 2-diazo-1,2-diarylethanones | 1 |
11 | 20years | 7 |
12 | 36-hours | 1 |
13 | 37-year | 2 |
14 | 387.61 | 1 |
15 | 39-year | 2 |
16 | 41-year | 1 |
17 | 43-year | 1 |
18 | 48-yr | 1 |
19 | 51-year | 4 |
20 | 52-year | 2 |
21 | 54year- | 1 |
22 | 55-year- | 1 |
23 | 56-year | 2 |
24 | 57-year | 1 |
25 | 61-year | 3 |
26 | 63-year | 1 |
27 | 71-year | 1 |
28 | 76-year | 2 |
29 | 770-221 | 1 |
30 | 9weeks | 2 |
31 | acyls-groups | 1 |
32 | allopatrically-formed | 1 |
33 | aminoestrogens | 1 |
34 | anastrozole.ais | 1 |
35 | anhydrophytosphingosines | 1 |
36 | anokye | 3 |
37 | arm-parallel | 2 |
38 | asphytic | 2 |
39 | assay® | 1 |
40 | at-biased | 1 |
41 | avaoli | 1 |
42 | aw06 | 1 |
43 | balanced-randomized | 1 |
44 | bavry | 1 |
45 | beta-hsdh | 3 |
46 | bites.1 | 1 |
47 | block/first | 1 |
48 | blood-draw | 1 |
49 | brush-applied | 1 |
50 | catecholamine-o-methyltransferase | 1 |
51 | centuries | 404 |
52 | century | 1,153 |
53 | chayamansa | 4 |
54 | chidren | 1 |
55 | chlorocarbons | 1 |
56 | cis-aligned | 1 |
57 | cis-vertices | 1 |
58 | citadels | 1 |
59 | climbs | 2 |
60 | cohorts.furthermore | 1 |
61 | complications.there | 1 |
62 | course-year | 1 |
63 | d.p.i. | 4 |
64 | days/weeks | 1 |
65 | decade | 2,525 |
66 | decades | 2,910 |
67 | decennium | 1 |
68 | depression.twenty-three | 1 |
69 | dgou | 4 |
70 | di-nor-sesquiterpenoids | 1 |
71 | direct-personal | 5 |
72 | due-date | 1 |
73 | electron-volts | 1 |
74 | endoscopists-in-training | 2 |
75 | ergotamine-type | 1 |
76 | eu-countries | 2 |
77 | experienes | 1 |
78 | fast-access | 1 |
79 | fixed-cadence | 1 |
80 | follow-up/death | 2 |
81 | formicicum | 1 |
82 | fourteen-week | 1 |
83 | free-market | 1 |
84 | go-trial | 1 |
85 | groups.however | 1 |
86 | guoup | 1 |
87 | half-century | 15 |
88 | half-decade | 1 |
89 | heathcare | 1 |
90 | high-index | 2 |
91 | homo-oligomer | 2 |
92 | hormokines | 1 |
93 | immunohematologic | 1 |
94 | intensions | 1 |
95 | interglacial | 2 |
96 | issue/month | 1 |
97 | itbs-treatment | 1 |
98 | lodging | 7 |
99 | m539i | 1 |
100 | microtechnic | 1 |
101 | millennia | 44 |
102 | minutes.pimecrolimus | 1 |
103 | mulilo | 3 |
104 | naphthofuranoxepin | 1 |
105 | non-furanocoumarins | 1 |
106 | o05 | 1 |
107 | oligostilbenoids | 1 |
108 | p53-ict | 1 |
109 | parent/grandparent | 1 |
110 | pcv-doses | 3 |
111 | picoseconds | 5 |
112 | placebo-responders | 1 |
113 | polyprocess | 1 |
114 | pseudoknots | 1 |
115 | re-proposed | 1 |
116 | regio-isomers | 1 |
117 | rheas | 1 |
118 | rhg-csfs | 2 |
119 | rippstein | 1 |
120 | schedules-birth | 1 |
121 | sictts | 1 |
122 | souzae | 2 |
123 | spiroketals | 1 |
124 | studies.overall | 1 |
125 | studies/metaanalyses | 1 |
126 | subpatterns | 1 |
127 | tetrabutylester | 2 |
128 | thousand-fold | 4 |
129 | three-month-period | 1 |
130 | town-pantelimon | 1 |
131 | typia | 1 |
132 | videocamera | 2 |
133 | year-groups | 1 |
134 | years-first | 1 |
135 | δ-retroviruses | 1 |
1 | 55-year- | 1 |
2 | 54year- | 1 |
3 | d.p.i. | 4 |
4 | bites.1 | 1 |
5 | 770-221 | 1 |
6 | 387.61 | 1 |
7 | 0.40+/-0.43 | 1 |
8 | o05 | 1 |
9 | aw06 | 1 |
10 | 151.8/79.7 | 1 |
11 | millennia | 44 |
12 | typia | 1 |
13 | videocamera | 2 |
14 | chayamansa | 4 |
15 | immunohematologic | 1 |
16 | microtechnic | 1 |
17 | asphytic | 2 |
18 | 1-s.d | 2 |
19 | brush-applied | 1 |
20 | allopatrically-formed | 1 |
21 | cis-aligned | 1 |
22 | at-biased | 1 |
23 | re-proposed | 1 |
24 | balanced-randomized | 1 |
25 | thousand-fold | 4 |
26 | three-month-period | 1 |
27 | souzae | 2 |
28 | fixed-cadence | 1 |
29 | decade | 2,525 |
30 | half-decade | 1 |
31 | depression.twenty-three | 1 |
32 | ergotamine-type | 1 |
33 | heathcare | 1 |
34 | complications.there | 1 |
35 | cohorts.furthermore | 1 |
36 | catecholamine-o-methyltransferase | 1 |
37 | due-date | 1 |
38 | anokye | 3 |
39 | lodging | 7 |
40 | endoscopists-in-training | 2 |
41 | beta-hsdh | 3 |
42 | follow-up/death | 2 |
43 | issue/month | 1 |
44 | schedules-birth | 1 |
45 | m539i | 1 |
46 | avaoli | 1 |
47 | fourteen-week | 1 |
48 | interglacial | 2 |
49 | go-trial | 1 |
50 | direct-personal | 5 |
51 | arm-parallel | 2 |
52 | studies.overall | 1 |
53 | formicicum | 1 |
54 | decennium | 1 |
55 | chidren | 1 |
56 | rippstein | 1 |
57 | naphthofuranoxepin | 1 |
58 | town-pantelimon | 1 |
59 | mulilo | 3 |
60 | guoup | 1 |
61 | 41-year | 1 |
62 | 51-year | 4 |
63 | 61-year | 3 |
64 | 71-year | 1 |
65 | 52-year | 2 |
66 | 43-year | 1 |
67 | 63-year | 1 |
68 | 56-year | 2 |
69 | 76-year | 2 |
70 | 37-year | 2 |
71 | 57-year | 1 |
72 | 39-year | 2 |
73 | course-year | 1 |
74 | homo-oligomer | 2 |
75 | tetrabutylester | 2 |
76 | groups.however | 1 |
77 | 18-yr | 1 |
78 | 48-yr | 1 |
79 | rheas | 1 |
80 | climbs | 2 |
81 | oligostilbenoids | 1 |
82 | di-nor-sesquiterpenoids | 1 |
83 | picoseconds | 5 |
84 | cis-vertices | 1 |
85 | decades | 2,910 |
86 | eu-countries | 2 |
87 | centuries | 404 |
88 | experienes | 1 |
89 | hormokines | 1 |
90 | anhydrophytosphingosines | 1 |
91 | 1,2,3,4-tetrazines | 1 |
92 | 2-diazo-1,2-diarylethanones | 1 |
93 | pcv-doses | 3 |
94 | δ-retroviruses | 1 |
95 | studies/metaanalyses | 1 |
96 | rhg-csfs | 2 |
97 | anastrozole.ais | 1 |
98 | days/weeks | 1 |
99 | 9weeks | 2 |
100 | spiroketals | 1 |
101 | citadels | 1 |
102 | aminoestrogens | 1 |
103 | non-furanocoumarins | 1 |
104 | chlorocarbons | 1 |
105 | intensions | 1 |
106 | subpatterns | 1 |
107 | year-groups | 1 |
108 | acyls-groups | 1 |
109 | 20years | 7 |
110 | 10-20years | 1 |
111 | 15years | 5 |
112 | placebo-responders | 1 |
113 | regio-isomers | 1 |
114 | 36-hours | 1 |
115 | fast-access | 1 |
116 | polyprocess | 1 |
117 | electron-volts | 1 |
118 | -participants | 1 |
119 | pseudoknots | 1 |
120 | sictts | 1 |
121 | minutes.pimecrolimus | 1 |
122 | 12-days | 1 |
123 | p53-ict | 1 |
124 | free-market | 1 |
125 | itbs-treatment | 1 |
126 | parent/grandparent | 1 |
127 | years-first | 1 |
128 | block/first | 1 |
129 | dgou | 4 |
130 | blood-draw | 1 |
131 | high-index | 2 |
132 | century | 1,153 |
133 | half-century | 15 |
134 | bavry | 1 |
135 | assay® | 1 |